Precision medicine

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage the assays?

We explore the preventive genomics clinics at two Boston healthcare systems to learn whether they could be the future of precision medicine

Keeping tests close to home allows the lab and the clinic to work closely together

With better assays comes the need for better controls – are liquid biopsies and cell line-derived controls a match made in heaven?

Findings from the NCI-MATCH precision medicine trial provide insight into tumor gene testing for targeted cancer treatment

A whistle-stop roundup of the latest research in pathology and laboratory medicine

Keeping molecular testing in-house offers benefits for pathologists, oncologists, and patients

An expert roundtable on the future of molecular medicine in pathology

How precision medicine is expanding the laboratory’s role – and its responsibilities – in patient care

A timeline of key molecular pathology events, from Sanger sequencing to 100,000 genomes